Brief: IceCure Medical Says FDA Advisory Panel Meeting Date For Marketing Authorization Of ProSense Scheduled For Nov 7
12/09/2024 13:43
Sept 12 (Reuters) - Icecure Medical Ltd ICCM.O :
* ICECURE MEDICAL LTD: FDA ADVISORY PANEL MEETING DATE FOR
MARKETING AUTHORIZATION OF PROSENSE SCHEDULED FOR NOVEMBER 7
* ICECURE MEDICAL LTD - FDA DECISION REGARDING MARKETING
AUTHORIZATION OF PROSENSE® EXPECTED BY EARLY 2025
Source text for Eikon: ID:nPn6vkftba
Further company coverage: ICCM.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Icecure Medical
See all newsIcecure Medical Ltd reports results for the quarter ended June 30 - Earnings Summary
Israel's IceCure Medical H1 revenue rises on higher system, probe sales
Brief: Icecure Sio Petitions Nccn To Include Cryoablation In Breast Cancer Treatment Guidelines, Citing Icecure's FDA Clearance Of Prosense®
NASDAQ RESUMED AT 09:55 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:45 AM